Hydroxyurea Therapy for Children With Sickle Cell Anemia in Sub‐Saharan Africa: Rationale and Design of the REACH Trial

BACKGROUND: Sickle cell anemia (SCA) is an inherited hematological disorder that causes a large but neglected global health burden, particularly in Africa. Hydroxyurea represents the only available disease‐modifying therapy for SCA, and has proven safety and efficacy in high‐resource countries. In s...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Pediatr Blood Cancer
Päätekijät: McGann, Patrick T., Tshilolo, Léon, Santos, Brigida, Tomlinson, George A., Stuber, Susan, Latham, Teresa, Aygun, Banu, Obaro, Stephen K., Olupot‐Olupot, Peter, Williams, Thomas N., Odame, Isaac, Ware, Russell E.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: John Wiley and Sons Inc. 2015
Aiheet:
Research Articles
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4825070/
https://ncbi.nlm.nih.gov/pubmed/26275071
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.25705
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia